TB Continues Being The Leading Global Infectious Killer In Spite of Progress

T.B. is still the leading the list of infectious killer diseases despite the availability of revolutionary medicine and treatment. the American Thoracic Society joins the WHO is calling for redoubled efforts to end the global T.B. pandemic by 2030, the goal set by the global community in the United Nations Political Declaration to End Tuberculosis on Sept. 26, 2018.

The WHO report finds that TB remains the leading global infectious disease killer. WHO's data shows that while T.B. deaths declined slightly, from 1.6 million in 2017 to 1.5 million in 2018, the number of new T.B. cases remained steady at about 10 million in both 2017 and 2018. On drug-resistant, T.B. (D.R.), WHO reports slight improvement in detection and treatment initiation, with one in three of the approximately half a million people with DR-TB enrolled in treatment in 2018, up from one in four enrolled in treatment in 2017.

"The historic U.N. Political Declaration to End T.B. secured global commitments to put us on track to finally ending T.B. We need to build on the increased global awareness and scientific advances in new T.B. diagnostics, treatments, and prevention strategies," said T.B. expert and ATS International Health Committee Chair, David Lewinsohn, MD. "Now is the time for countries, including the U.S., to redouble efforts to eliminate T.B."

Dr. Lewinsohn added, "In the U.S., we urge the Administration and Congress to ensure that we meet the U.S. commitment to end T.B. by fully funding our global and domestic T.B. programs through USAID, CDC and the Global Fund and T.B. research through the National Institutes of Health. We urge Congress to pass the End T.B. Now Act of 2019, S. 2438, and the Comprehensive T.B. Elimination Act, S. 834/H.R. 3080."

"The ATS, originally founded as the American Sanitorium Association in 1905, and our more than 16,000 worldwide members pledge to continue our work to eliminate T.B. In collaboration with the WHO and other partners, we have produced international standards of care and provided technical assistance in implementing these standards and other T.B. control, treatment, and prevention strategies in 23 countries," noted ATS President James Beck, MD.

Source-Eurekalert